BGM
BGM
NASDAQ · Pharmaceuticals

Bgm Group Ltd

$0.25
0.00 (-1.64%)
As of Sep 22, 3:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
152.21M
Net Income
-80,062,146
Gross Margin
16.6%
Profit Margin
-52.6%
Rev Growth
-16.4%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 16.6% 16.6% 33.1% 33.1%
Operating Margin -33.2% -29.9% 16.8% 14.4%
Profit Margin -52.6% -50.0% 11.7% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 152.21M 182.03M 106.35M 109.96M
Gross Profit 25.33M 30.29M 35.22M 36.42M
Operating Income -50,504,456 -54,357,821 17.84M 15.80M
Net Income -80,062,146 -86,170,690 12.42M 13.50M
Gross Margin 16.6% 16.6% 33.1% 33.1%
Operating Margin -33.2% -29.9% 16.8% 14.4%
Profit Margin -52.6% -50.0% 11.7% 12.3%
Rev Growth -16.4% -16.4% +7.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 233.0K 233.0K 23.86M 26.94M
Total Equity 56.82M 56.82M 126.32M 122.05M
D/E Ratio 0.00 0.00 0.19 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -44,645,671 -50,721,582 22.69M 21.79M
Free Cash Flow 8.29M 10.61M